Αποτελέσματα Αναζήτησης
21 Αυγ 2024 · Is Asensus Surgical stock a Buy, Sell or Hold? Asensus Surgical stock has received a consensus rating of buy. The average rating score is and is based on 8 buy ratings, 2 hold ratings,...
21 Αυγ 2024 · KARL STORZ to acquire Asensus for $0.35 per share in cash Creating a leading surgical robotics division within KARL STORZ RESEARCH TRIANGLE PARK, N.C., June 07, 2024 (GLOBE NEWSWIRE) -- Asensus Surgic...
22 Αυγ 2024 · Should You Buy or Sell Asensus Surgical Stock? Get The Latest ASXC Stock Analysis, Price Target, Earnings Estimates, and Headlines at MarketBeat.
17 Ιουν 2024 · Asensus Surgical Inc. ASXC gets into a definitive merger agreement with KARL STORZ Endoscopy-America, Inc., a wholly owned subsidiary of KARL STORZ SE & Co. KG. The merger agreement states that...
30 Ιουλ 2024 · Asensus, which was previously called Transenterix, entered into a non-binding agreement to be acquired by Karl Storz for $0.35 per share in cash, or roughly $95 million, in April. Under the terms of the agreement, Karl Storz provided a $20 million bridge loan and secured a 10-week exclusivity period to perform due diligence.
3 Απρ 2024 · The preliminary agreement, a non-binding letter of intent, could lead to KARL STORZ acquiring all outstanding shares of Asensus at $0.35 per share, a 66.7% premium over the closing price on...
7 Ιουν 2024 · On Friday, KARL STORZ Endoscopy-America, Inc. agreed to acquire Asensus Surgical Inc. (NYSE: ASXC) for $0.35 per share in cash. KARL STORZ is a wholly-owned direct subsidiary of KARL...